PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 63 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,979 | -39.5% | 49,184 | -11.9% | 0.00% | – |
| Q2 2023 | $251,271 | -6.7% | 55,838 | +18.2% | 0.00% | – |
| Q1 2023 | $269,319 | -34.4% | 47,249 | -30.5% | 0.00% | – |
| Q4 2022 | $410,750 | -21.2% | 68,005 | -13.8% | 0.00% | -100.0% |
| Q3 2022 | $521,000 | -13.9% | 78,881 | -31.9% | 0.00% | 0.0% |
| Q2 2022 | $605,000 | +271.2% | 115,867 | +390.7% | 0.00% | – |
| Q1 2022 | $163,000 | -70.0% | 23,611 | +88.2% | 0.00% | -100.0% |
| Q1 2021 | $544,000 | – | 12,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $66,362,000 | 1.23% |
| Baker Brothers Advisors | 10,123,824 | $66,918,000 | 0.44% |
| HHLR ADVISORS, LTD. | 583,333 | $3,856,000 | 0.10% |
| CAXTON ASSOCIATES LP | 85,992 | $568,000 | 0.08% |
| Virtus ETF Advisers LLC | 24,180 | $160,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 54,173 | $358,000 | 0.05% |
| DENALI ADVISORS LLC | 8,200 | $54,000 | 0.03% |
| PDT Partners, LLC | 12,641 | $84,000 | 0.01% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 2,402,595 | $15,881,153,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,949 | $244,000 | 0.01% |